Although the interaction between Cav1 and multiple signaling molecules such as MAP kinase family and Smad has been studied extensively, it is still not clear whether these Cav1-mediated signaling pathways can be targeted as prospective therapies in liver fibrosis [4,9,25,26,27]. Here, CAV1 is linked to Hepatic fibrosis.